Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Change in Account Payables: 2013-2025

Historic Change in Account Payables for Coherus Oncology (CHRS) over the last 12 years, with Sep 2025 value amounting to -$15.3 million.

  • Coherus Oncology's Change in Account Payables rose 69.61% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 26.56%. This contributed to the annual value of -$3.9 million for FY2024, which is 116.57% down from last year.
  • Latest data reveals that Coherus Oncology reported Change in Account Payables of -$15.3 million as of Q3 2025, which was down 25.33% from -$12.2 million recorded in Q2 2025.
  • Coherus Oncology's 5-year Change in Account Payables high stood at $39.5 million for Q2 2024, and its period low was -$50.4 million during Q3 2024.
  • Over the past 3 years, Coherus Oncology's median Change in Account Payables value was $6.0 million (recorded in 2023), while the average stood at $486,727.
  • In the last 5 years, Coherus Oncology's Change in Account Payables slumped by 1,000.88% in 2021 and then skyrocketed by 2,243.35% in 2022.
  • Over the past 5 years, Coherus Oncology's Change in Account Payables (Quarterly) stood at -$29.6 million in 2021, then soared by 105.40% to $1.6 million in 2022, then crashed by 149.03% to -$785,000 in 2023, then spiked by 907.90% to $6.3 million in 2024, then skyrocketed by 69.61% to -$15.3 million in 2025.
  • Its Change in Account Payables was -$15.3 million in Q3 2025, compared to -$12.2 million in Q2 2025 and $13.0 million in Q1 2025.